IL4 and neoplasm: In another model the vaccination protocol consisted of intratumoral delivery of DCs previously modified with a recombinant adenoviral vector encoding IFN-α in combination with irradiated tumor cells engineered to express IL-4 or GM-CSF, resulting in stronger tumor specific CTL responses in the cervical lymph node and increased survival [339].